NEW YORK--(BUSINESS WIRE)--Dec. 22, 2005--Axonyx Inc. (NASDAQ: AXYX), a U.S.-based biopharmaceutical company, today announced that it received notice on December 21, 2005 from The Nasdaq Stock Market, Inc. that the minimum bid price of the Company's common stock had fallen below $1.00 for 30 consecutive business days and that the Company was therefore not in compliance with Nasdaq Marketplace Rule 4310(c)(4).
